Fuan Pharmaceutical (Group) Co., Ltd.

Equities

300194

CNE1000011G4

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-07-11 pm EDT 5-day change 1st Jan Change
3.91 CNY +0.51% Intraday chart for Fuan Pharmaceutical (Group) Co., Ltd. +2.09% -10.73%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024 CI
Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 CI
Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023 CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Fuan Pharm Unit's Hemorrhage Drug Gets Registration Certificate from China's Drug Regulator MT
Drugs of Fuan Pharma's Unit Passes Regulatory Evaluation MT
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Fuan Pharma Unit Gets Marketing Approval for Two Drugs MT
Fuan Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023 CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Fuan Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Fuan Pharmaceutical Registers New Respiratory Drug MT
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Fuan Pharmaceutical Co., Ltd. Announces Management Appointments CI
Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Fuan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Fuan Pharmaceutical Co., Ltd.(XSEC:300194) dropped from S&P Global BMI Index CI
Fuan Pharmaceutical Co., Ltd. Announces Implementation of Profit Distribution Plan for A Shares for the Year 2020, Payable on 14 May 2021 CI
Fuan Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020 CI
Fuan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Chart Fuan Pharmaceutical (Group) Co., Ltd.
More charts
Fuan Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceutical products. The Company’s main business includes research and development of pharmaceutical products and production and sales of pharmaceutical intermediates, chemical active pharmaceutical ingredients and preparations. The Company’s products include antibiotics, anti-tumor, specialty medicines and other categories of medicines. The Company’s other business includes medicine distribution and other businesses. The Company operates its business in the domestic and overseas markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 300194 Stock
  4. News Fuan Pharmaceutical (Group) Co., Ltd.
  5. Fuan Pharma Unit Gets Marketing Approval for Two Drugs